Showing 20 of 126 recruiting trials for “b-lymphoblastic-leukemialymphoma-with-hyperdiploidy”
Vitamin A and D Supplementation in Allogeneic HCT
Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases
Decitabine, Venetoclax and Blinatumomab for Maintenance Following HSCT in Patients With Ph-Negative B-ALL
👨⚕️ Xiaowen Tang, Ph.D, The First Affiliated Hospital of Soochow University📍 1 site📅 Started Apr 2024View details ↗
Clinical Trial of CD19 and CD22 CAR Sequential Therapy Versus Single CD19 CAR Bridging to HSCT for r/r B-ALL Patients
RecruitingNCT06025682 ↗
Retrospective Observational Study on Infective Complications and Outcome of Patients With ALL Treated With INO
👨⚕️ Livio Pagano, Policlinico Universitario A. Gemelli, IRCCS-Università Cattolica del Sacro Cuore, Roma📍 1 site📅 Started Apr 2024View details ↗
A Study of 19-28z/IL-18 in People With Acute Lymphoblastic Leukemia (ALL)
Study of CD19-directed Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia
👨⚕️ Aimee C. Talleur, MD, St. Jude Children's Research Hospital📍 1 site📅 Started Feb 2024View details ↗
Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)
A Novel CAR-T Combined Expression of IL-15 in the Treatment of Malignant Hematological Tumors
A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies
Olverembatinib Plus Venetoclax and Dexamethasone for Treatment-naïve Ph+ Acute Lymphoblastic Leukemia
Universal 4SCAR7U Targeting CD7-positive Malignancies
RecruitingNCT05809284 ↗
Determining the Mechanisms of Loss of CAR T Cell Persistence
👨⚕️ Persis Amrolia, BSc,MBBS,PhD, UCL Institute of Child Health📍 3 sites📅 Started Oct 2023View details ↗
Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma
Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blinatumomab and SCT
👨⚕️ Nicola Goekbuget, MD, Department of Medicine, Hematology and Oncology, Goethe University Frankfurt, Frankfurt, Germany📍 85 sites📅 Started Jul 2023View details ↗
Daratumumab for Chemotherapy-Refractory Minimal Residual Disease in T Cell ALL
CAR T Cells in the Treatment of Refractory and Relapsed CD19+ B Cell Neoplasms
Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA with High Risk T-Cell ALL & Lymphoma
A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →